Loading
institutionsInstitution
National Cancer Centre Singapore
Singapore's national cancer centre and the largest cancer facility in the country, with a proton centre and leading Asian research in liver and lung cancer genomics.
Also called: NCCSSingHealth Duke-NUS Oncology Academic Clinical Programme
Overview
The National Cancer Centre Singapore opened in 1999 and moved into a new purpose-built building on the Outram campus in 2023 that houses South-east Asia's first hospital-based proton therapy centre (Goh Cheng Liang Proton Therapy Centre). It treats the majority of Singapore's public-sector cancer patients and, with Duke-NUS Medical School and the Genome Institute of Singapore, has produced influential research on Asian lung cancer in never-smokers, hepatocellular carcinoma and cholangiocarcinoma genomics (including the liver-fluke associated cholangiocarcinoma genome), nasopharyngeal cancer and cancer immunotherapy. NCCS runs the Singapore Translational Cancer Consortium, a large phase 1 unit, and cell therapy programmes with the Singapore Immunology Network, and it coordinates national screening and survivorship initiatives.
Location
Singapore, SG
Type
cancer center · Duke-NUS Medical School
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#107 · 38 points (0 Newsweek + 0 NCI + 38 from 19 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-16.
Matched to National Cancer Centre Singapore, including child institutions. 493 works · 5,212 citations · 67% open access · 14% clinical trials · 3% reviews.
Oncology works per year
772022
992023
1042024
1262025
872026
Most works
- Rebecca Dent37 works
- Jason Yongsheng Chan33 works
- Brian K. P. Goh28 works
- Wan‐Teck Lim25 works
- Joe Yeong22 works
- Daniel S.W. Tan21 works
- Jingmei Li20 works
- Bin Tean Teh19 works
- Tira J. Tan19 works
- Ye Xin Koh19 works
Most cited
- Proton therapy
- Asian lung and liver cancer genomics
- Phase 1 unit
- Cholangiocarcinoma research
- Cell therapy
Goh Cheng Liang
Nippon Paint magnate whose Goh Foundation gave $50 million for Singapore's public proton therapy centre
Proton therapyCancer care in Asia
His Goh Foundation's $50 million gift built the Goh Cheng Liang Proton Therapy Centre at the National Cancer Centre Singapore, the only public proton therapy service in the country.
Lim Soon Thye
Chief Executive Officer
LymphomaMedical oncologyHealth system leadership
Lymphoma specialist and Chief Executive Officer of the National Cancer Centre Singapore, the country's largest public cancer centre.
Rebecca Dent
Deputy Chief Executive Officer (Clinical)
Breast cancerTriple-negative breast cancerClinical trials
Breast medical oncologist and Deputy CEO for clinical operations at the National Cancer Centre Singapore, an international leader in triple-negative breast cancer trials.
Similar pages
- InstitutionHokkaido University Hospital
Shares Hitachi (particle therapy), Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy, Hepatocellular carcinoma.
- InstitutionShizuoka Cancer Center
Shares Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Whole-exome & whole-genome sequencing, Proton therapy, Head and neck squamous cell carcinoma.
- InstitutionTaipei Veterans General Hospital
Shares Hitachi (particle therapy), CAR-T cell therapy, Hepatocellular carcinoma, Colorectal cancer.
- InstitutionChang Gung Memorial Hospital
Shares Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy, Hepatocellular carcinoma, Head and neck squamous cell carcinoma.
- TermIntrahepatic, perihilar, distal and gallbladder cancer
Shares IDH1 / IDH2, FGFR2, Biliary tract cancer (cholangiocarcinoma).
- InstitutionNational Cancer Center Korea
Shares Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy, Hepatocellular carcinoma, Colorectal cancer.
- InstitutionApollo Hospitals (Apollo Cancer Centres)
Shares Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy, Head and neck squamous cell carcinoma, Non-small-cell lung cancer.
- InstitutionCancer Center Clínica Universidad de Navarra / CIMA
Shares TIL therapy, Proton therapy, CAR-T cell therapy, Hepatocellular carcinoma.